Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	-36.96	8.12	12.88
Graham Fair Price	inf	0.00	9.15
PEG	inf	0.00	0.09
Price/Book	inf	0.00	0.59
Price/Cash Flow	inf	0.00	59.29
Prices/Earnings	inf	0.00	6.22
Price/Sales	inf	0.00	2.20
Price/FCF	inf	0.00	59.29
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	-13.31	0.14	0.16
Operating Margin	-13.31	0.14	0.16
ROA	-71.52	< 0.005	0.02
ROE	0.02	< 0.005	-65.69
ROIC	0.02	0.04	70.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	1.04	0.05	1950.20
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	0.32	-0.15	-53.32
EPS QOQ	0.67	-1.37	105.00
FCF QOQ	-0.37	0.38	3.47
Revenue QOQ	0.08	-0.02	-72.35
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2.94	3.52	20.01
Days Sales Outstanding (DSO)	4.53	9.78	115.72
Inventory Turnover	30.65	25.54	-16.67
Debt/Capitalization	0.20	0.27	35.90
Quick Ratio	0.16	0.26	61.36
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	12.50	0.00	inf
Cash	0.01	0.00	inf
Capex	-0.41	0.00	inf
Free Cash Flow	0.12	0.00	inf
Revenue	3.36	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	0.33	0.32	-3.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.84	8.12	111.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating